Shares of RAPT Therapeutics Inc. (RAPT) are down nearly 42 percent from their 52-week high of $51.21, recorded in January of this year, and trade around $29.
Shares of Innate Pharma S.A. (IPHA) are down nearly 50 percent from their 52-week high of $8.24, recorded in January of this year, and trade around $4.